Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Sin3 histone deacetylase complex (often called the SIN3-HDAC complex) is a ubiquitous, conserved, multi-protein chromatin-modifying complex involved in the regulation of gene expression through histone deacetylation. It acts as a scaffold for the assembly of histone deacetylases (primarily HDAC1 and HDAC2), transcription factors, and chromatin adaptor proteins, thus functioning as both a co-repressor and, in some contexts, a co-activator of gene transcription[1][3][5]. The complex can be subdivided into at least two forms (SIN3L, SIN3S), which differ in protein composition and chromatin targeting, allowing the complex to participate in regulation of both promoter and gene body chromatin[5]. Sin3 complexes play critical roles in mammalian development, maintenance of stem cell pluripotency, cell cycle progression, apoptosis, and are implicated in the pathogenesis of numerous cancers by regulating key genes involved in cell proliferation and differentiation[1][3][5]. Therapeutically, the SIN3-HDAC complex is targeted indirectly by histone deacetylase inhibitors, which inhibit the catalytic subunits, leading to global changes in chromatin structure and gene expression. Safety and biomarker strategies focus on the degree of histone acetylation and transcriptional response as indirect readouts for complex inhibition.
Inhibitors targeting the HDAC enzymatic subunits (e.g., HDAC1/2) prevent histone deacetylation, resulting in increased histone acetylation, relaxed chromatin structure, and altered gene expression[1][3][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sin3 histone deacetylase complex (SIN3-HDAC complex).